Overview
Maria Ruiz-Apellaniz practices practicing medicine in Madrid, Spain.
Her clinical expertise encompasses Pheochromocytoma, Neuroendocrine Tumor, and Adrenal Cancer.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Maria Ruiz-Apellaniz
Is Maria Ruiz-Apellaniz a top-rated expert for Pheochromocytoma?
MediFind is an objective health platform that identifies experts based on real-world data. Maria Ruiz-Apellaniz is classified as an Experienced expert for Pheochromocytoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Maria Ruiz-Apellaniz participate in research or clinical trials?
Yes. Maria Ruiz-Apellaniz has published 8 articles and abstracts on conditions like Pheochromocytoma. You can view a list of Maria Ruiz-Apellaniz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal CancerMs. Ruiz-Apellaniz isExperienced. Learn about Adrenal Cancer.
- Neuroendocrine TumorMs. Ruiz-Apellaniz isExperienced. Learn about Neuroendocrine Tumor.
- PheochromocytomaMs. Ruiz-Apellaniz isExperienced. Learn about Pheochromocytoma.